Raben David Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$405,900.00

Insider Activity of Raben David

According to the SEC Form 4 filings, Raben David, being in a position of

  1. Chief Medical Officer at Bicara Therapeutics Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 33906 shares for $654,216,
    over all time since 2025-10-09, has bought 0 shares, and sold 55906 shares for $1.06M.

Biography of Raben David

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $654,2166100

Comparison of Insiders on Amount of Buys and Sells

2026-04-27SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Medical Officer
5,500
0.0102%
$22.88$125,830+1.2%
2026-03-25SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Medical Officer
5,500
0.0102%
$18.95$104,229+21.23%
2026-03-04SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Medical Officer
16,300
0.0297%
$18.52$301,920+18.66%
2026-03-03SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Medical Officer
200
0.0004%
$18.45$3,690+22.71%
2025-11-25SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Medical Officer
906
0.0017%
$18.84$17,071+8.5%
2025-11-24SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Medical Officer
5,500
0.0103%
$18.45$101,475+6.01%
2025-10-09SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Medical Officer
22,000
0.0407%
$18.45$405,900+6.24%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.